November 12, 2001
Soft Gel Technologies Introduces Oral Form of Hyaluronic Acid
LOS ANGELES--Soft Gel Technologies Inc.(www.soft-gel.com) released an oral version of hyaluronic acid called Injuv™. This compound was once limited to injectable or topical form because of its large molecular weight. However, this patent-pending ingredient has a lower molecular weight so the acid can be taken orally. Injuv contains a higher concentration (9 percent) of hyaluronic acid, which is three times the amount found in other forms. It also has a high absorption rate in the body because of its low molecular weight. Hyaluronic acid is helpful in maintaining healthy skin and joints, and is an anti-aging agent and can sustain ideal immune function. For more information, visit Booth #1107 at SupplySide West.
You May Also Like
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023
More bioavailable hyaluronic acid complex for today’s beauty-from-within consumer – snapshotSep 18, 2023